Dividends

ORMPOramed Pharmaceuticals

StockNasdaqUnited StatesHealth careEU retail investors: available

+3.6% today · +95.9% over a year

1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 61% of the instruments we score

Dividend yield 6.25%.

Oramed Pharmaceuticals (ORMP) dividends: trailing yield 6.25%, Dividend Safety 24/100.

Trailing 12-month yieldA high yield can signal risk rather than safety: payouts may be cut, and part of a fund's distribution may be your own capital returned.
6.25%
Dividends per share, last 12 months
$0.25
Payments per year
Irregular
Dividend safety0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.
24 / 100
Unsafe

Yield after tax (estimate)

Before tax → After tax, CY non-dom

Last 12 months
6.25% → 5.15%

Of every 100 paid out

Withheld at source (United States)
15.00%
Cyprus Special Defence Contribution (after credit for foreign tax)
0.00%
Cyprus GeSY health contribution
2.65%
You keep
82.35%
  • Source country assumed: United States (from the issuer’s data). Depositary receipts and companies listed outside their home country may be taxed by that home country.
  • US rate 15 % assumes a W-8BEN form is on file with your broker (US–Cyprus treaty); without it the US withholds 30 %.
  • GeSY 2.65 % applies to dividends and interest of every Cyprus resident, domiciled or not, up to €180,000 of income a year.

Cyprus resident, domiciled: 5.15%

Estimate, not tax advice: published rules as of 2026-10-14 for the profile chosen; your broker’s withholding and your own situation can differ. How we estimate tax

Next payment

No upcoming payment has been announced yet.

Dividend profile

Years without a lower dividend
0
Years without a cut of over 10 %
0
Payout ratio (earnings)
6%

Annual total matches the company's SEC filing

A high yield is not a high return: payouts can come from your own capital and can be cut.

Our rules see a meaningful risk that this dividend is cut.

Serious warning. Yield at least twice the peer median while the payout is not covered or debt is high. More in the glossary →Yield at least twice the peer median while the payout is not covered or debt is high.

Caution. Dividend Safety below 40 points. More in the glossary →Dividend Safety below 40 points.

Payment history

Amounts are per share on today's share count (adjusted for splits), before withholding tax.

Status
16 Jan 202627 Jan 2026$0.25RegularVerified2

Each payment is checked against up to 2 data feeds. Several feeds can share one upstream, so Verified needs two independent ones. Verified: two or more sources agree. Single source: not cross-checked yet. Sources disagree: the median is shown. Announced: declared, may still change.

What dividend safety is made of

0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.

Similar dividend payers

Same sector and region, closest in dividend yield.

PFEPfizer7.4%2—
PRGOPerrigo Company plc5.1%7—
EMBCEmbecta5.0%52—
BMYBristol-Myers Squibb4.1%391
ZTSZoetis3.2%55—
CVSCVS Health Corporation3.1%7025
ABBVAbbVie2.9%29—
ABTAbbott2.8%42—

A high yield is not a high return: payouts can come from your own capital and can be cut. Dividend calculator →